These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 23091805
1. Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period. Song DS, Bae SH. Clin Mol Hepatol; 2012 Sep; 18(3):258-67. PubMed ID: 23091805 [Abstract] [Full Text] [Related]
2. Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area. Bae SY, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Clin Mol Hepatol; 2012 Jun; 18(2):185-94. PubMed ID: 22893869 [Abstract] [Full Text] [Related]
3. Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates. Jeon SK, Lee JM, Joo I, Yoo J, Park JY. Eur Radiol; 2020 Sep; 30(9):4762-4771. PubMed ID: 32333148 [Abstract] [Full Text] [Related]
4. Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues. Yoon JH, Park JW, Lee JM. Korean J Radiol; 2016 Sep; 17(1):7-24. PubMed ID: 26798212 [Abstract] [Full Text] [Related]
5. The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area. Lin MT, Chang KC, Chou YP, Tseng PL, Yen YH, Wang CC, Tsai MC, Cheng YF, Eng HL, Wu CK, Hu TH. J Gastroenterol Hepatol; 2015 Feb; 30(2):345-51. PubMed ID: 25092265 [Abstract] [Full Text] [Related]
6. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Kim TH, Kim SY, Tang A, Lee JM. Clin Mol Hepatol; 2019 Sep; 25(3):245-263. PubMed ID: 30759967 [Abstract] [Full Text] [Related]
7. Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard. Esfeh JM, Hajifathalian K, Ansari-Gilani K. Clin Mol Hepatol; 2020 Jan; 26(1):54-59. PubMed ID: 31726817 [Abstract] [Full Text] [Related]
8. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis. Aby E, Phan J, Truong E, Grotts J, Saab S. J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761 [Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. Ungtrakul T, Mahidol C, Chun-On P, Laohapand C, Siripongsakun S, Worakitsitisatorn A, Vidhayakorn S, Boonchuay W, Dechma J, Sornsamdang G, Soonklang K, Sriprayoon T, Tanwandee T, Auewarakul CU. World J Gastroenterol; 2016 Sep 14; 22(34):7806-12. PubMed ID: 27678364 [Abstract] [Full Text] [Related]
10. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Lee JM, Park JW, Choi BI. Dig Dis; 2014 Sep 14; 32(6):764-77. PubMed ID: 25376295 [Abstract] [Full Text] [Related]
11. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India. Sood A, Midha V, Goyal O, Goyal P, Sood N, Sharma SK. Indian J Gastroenterol; 2014 Jan 14; 33(1):35-40. PubMed ID: 24222369 [Abstract] [Full Text] [Related]
12. [Screening for hepatocellular carcinoma]. Leone N, Rizzetto M. Minerva Med; 2005 Apr 14; 96(2):95-108. PubMed ID: 16172579 [Abstract] [Full Text] [Related]
13. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. Radiology; 2008 May 14; 247(2):311-30. PubMed ID: 18430871 [Abstract] [Full Text] [Related]
14. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development]. Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS. Korean J Gastroenterol; 2006 Nov 14; 48(5):321-6. PubMed ID: 17132920 [Abstract] [Full Text] [Related]
15. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. World J Gastroenterol; 2016 Jan 07; 22(1):262-74. PubMed ID: 26755875 [Abstract] [Full Text] [Related]
16. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. Manini MA, Sangiovanni A, Fornari F, Piscaglia F, Biolato M, Fanigliulo L, Ravaldi E, Grieco A, Colombo M, Study Participants. J Hepatol; 2014 May 07; 60(5):995-1001. PubMed ID: 24462368 [Abstract] [Full Text] [Related]
17. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Invest Radiol; 2009 Dec 07; 44(12):800-7. PubMed ID: 19838119 [Abstract] [Full Text] [Related]
18. Hepatocellular carcinoma: status in the era of liver transplantation. Singhal A, Jabbour N. J Okla State Med Assoc; 2009 Dec 07; 102(12):355-61. PubMed ID: 20131731 [No Abstract] [Full Text] [Related]
19. [Variable clinical symptoms of hepatocellular carcinoma]. Struve C, Heusermann U. Dtsch Med Wochenschr; 1988 Feb 26; 113(8):294-6. PubMed ID: 2449323 [Abstract] [Full Text] [Related]
20. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Mokrane FZ, Lu L, Vavasseur A, Otal P, Peron JM, Luk L, Yang H, Ammari S, Saenger Y, Rousseau H, Zhao B, Schwartz LH, Dercle L. Eur Radiol; 2020 Jan 26; 30(1):558-570. PubMed ID: 31444598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]